Processa Pharmaceuticals, Inc. Other Income
Processa Pharmaceuticals, Inc. (PCSA) reported Other Income of $20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-03-18
- Processa Pharmaceuticals, Inc. other income for the quarter ending 2017-12-31 was $509.00, a 72.93% decline year-over-year.
- Processa Pharmaceuticals, Inc. other income for the quarter ending 2017-09-30 was $1.28K, a 24.32% decline year-over-year.
- Processa Pharmaceuticals, Inc. other income for the quarter ending 2017-06-30 was $1.89K, a 117.38% increase year-over-year.
- Processa Pharmaceuticals, Inc. other income for the quarter ending 2017-03-31 was $1.50K, a 21300.00% increase year-over-year.
- Processa Pharmaceuticals, Inc. other income for fiscal 2025 was $20.00K.
- Processa Pharmaceuticals, Inc. other income for fiscal 2017 was $5.18K, a 16.32% increase from fiscal 2016.
- Processa Pharmaceuticals, Inc. other income for fiscal 2016 was $4.45K.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | $20.00K 10-K · filed 2026-03-18 | |||
| 2017-12-31 | $509.00 10-K · filed 2018-04-16 | $1.79K derived: sum of 2 quarters · filed 2018-04-16 | $3.68K derived: sum of 3 quarters · filed 2018-04-16 | $5.18K 10-K · filed 2018-04-16 |
| 2017-09-30 | $1.28K 10-K · filed 2018-04-16 | $3.17K derived: sum of 2 quarters · filed 2018-04-16 | $4.67K derived: sum of 3 quarters · filed 2018-04-16 | $6.55K derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-06-30 | $1.89K 10-K · filed 2018-04-16 | $3.39K derived: sum of 2 quarters · filed 2018-04-16 | $5.27K derived: sum of 3 quarters · filed 2018-04-16 | $6.96K derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-03-31 | $1.50K 10-K · filed 2018-04-16 | $3.38K derived: sum of 2 quarters · filed 2018-04-16 | $5.08K derived: sum of 3 quarters · filed 2018-04-16 | $5.95K derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-12-31 | $1.88K 10-K · filed 2018-04-16 | $3.58K derived: sum of 2 quarters · filed 2018-04-16 | $4.45K derived: sum of 3 quarters · filed 2018-04-16 | $4.45K 10-K · filed 2018-04-16 |
| 2016-09-30 | $1.70K 10-K · filed 2018-04-16 | $2.57K derived: sum of 2 quarters · filed 2018-04-16 | $2.57K derived: sum of 3 quarters · filed 2018-04-16 | |
| 2016-06-30 | $869.00 10-K · filed 2018-04-16 | $876.00 derived: sum of 2 quarters · filed 2018-04-16 | ||
| 2016-03-31 | $7.00 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |